ArticleCancer medicine2025

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.

Omar Alhalabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.